Multiple Sclerosis and stem cell therapy
Multiple sclerosis brings relapses, fatigue and the worry of what the next flare will take, even with modern medicines. Our approach focuses on calming the immune response and supporting the nervous system.
Medically reviewed by:Javier E. Garrido L.MD, MSc
On this page
What is multiple sclerosis?
Multiple sclerosis (MS) is a chronic disease in which the immune system attacks myelin, the protective coating around nerve fibers in the brain, spinal cord and optic nerves. The damage slows or blocks signals between the brain and the body. Most people start with relapsing-remitting MS, with flares followed by recovery, and many later move into a progressive phase with steady disability. MS is both an autoimmune and a neurodegenerative condition, which is why it appears in both categories. Every person’s course is different, so careful evaluation matters.

At Regeneration Clinic Panama, we take an individualized approach to your care. Our medical team will review your condition, medical history, and individual needs to help you understand your treatment options.
Book a ConsultationCommon signs and symptoms
Symptoms depend on where nerve damage occurs, so no two people with MS have quite the same experience.
- Fatigue
- Numbness or tingling
- Blurred or double vision, or eye pain
- Muscle weakness or stiffness
- Balance and walking problems
- Bladder and bowel problems
- Trouble with memory or concentration
- Electric-shock sensations when bending the neck
- Symptoms that worsen in heat
How MS is usually treated
Today, MS care is built around disease-modifying therapies, injections, pills and infusions such as ocrelizumab or natalizumab, that reduce relapses and new MRI lesions. Corticosteroids shorten flares, and rehabilitation and symptom medicines help with fatigue, spasticity and bladder problems. These treatments have changed life with relapsing MS. Options for progressive MS remain limited, and nerve damage that has already happened tends to remain. Many people keep looking for additional options to discuss with their neurologist.

How stem cell therapy works for MS
In MS, the immune system and inflammation damage myelin and nerve fibers. Mesenchymal stem cells regulate immune cells, reduce inflammation and release factors that support myelin-producing cells and nerve fibers. We use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords as part of selected personalized protocols. They are delivered by IV and, in selected cases, by other routes your physician recommends, and they work alongside your current MS treatment. The MS community is watching stem cells closely for a reason.
Every patient with multiple sclerosis has a different history and set of needs, so we start with a full evaluation. Your physician reviews your history, symptoms, previous treatments and test results before deciding whether a regenerative protocol is appropriate. When it is, cell therapy becomes one part of a personalized care plan.
Important: cellular therapy is an evolving area of medicine. Outcomes vary, and treatment decisions are made individually after a medical assessment.
What the research says
These studies were published by independent research teams. Their results are separate from our own patient outcomes.
- Source link
An open-label phase 1/2 study gave 35 people with MS umbilical cord mesenchymal stem cells by IV and into the spinal fluid, as one or two treatments, and followed them for 12 months.
No serious adverse events occurred and disability scores improved at 6 months in both groups; the study had no placebo group.
- Source link
A randomized, sham-controlled trial in 48 people with active progressive MS compared the person’s own bone marrow mesenchymal stem cells, given into the spinal fluid or by IV, with sham treatment over 14 months.
Fewer people in the mesenchymal stem cell groups had their disease worsen than in the sham group, with no serious treatment-related safety issues.
- Source link
An international randomized, double-blind crossover trial in 144 people with active MS compared one IV infusion of their own bone marrow mesenchymal stem cells with placebo.
The infusion was safe and well tolerated, and it did not reduce new inflammatory brain lesions on MRI at 24 weeks.
Evidence in MS is mixed: mesenchymal stem cells have a good safety record across trials, while results on lesions and disability vary, and a 2026 meta-analysis of randomized trials in progressive MS found no clear effect on disability scores.
Who may consider this
A personalized evaluation may be right for you if you:
- Have a confirmed diagnosis of relapsing or progressive MS from a neurologist
- Want to add a supportive option to your disease-modifying therapy
- Live with fatigue, mobility or other symptoms that still limit daily life
- Are able to travel to Panama City
- Are ready to share recent MRI scans and neurology notes
Our medical team decides suitability after reviewing each case.
What to expect
Before Treatment
Our team reviews your medical history and diagnostic information. We may recommend extra tests to understand your current health and whether you may be a candidate.
During Your Stay
If you are eligible, our medical team guides you through each stage of treatment and provides clinical support throughout.
After Treatment
We follow up at 1, 3, 6, 9 and 12 months after treatment and adjust your plan as needed.

Schedule a personalized consultation to discuss your medical history, treatment goals, and potential care options.
Book a ConsultationRelated articles
Real Patients. Real Results.
Patient stories share individual experiences. Results vary, and no outcome is promised.


- Takes less than 2 minutes
- No commitment
- Takes less than 2 minutes
- No commitment
Your questions
Read Full FAQAnswers about safety, cost and what to expect.
Our physicians review your MS medicines with your neurologist, because some therapies affect the immune system and timing matters. Any change is decided together with your own doctors.
HSCT uses chemotherapy to reset the immune system and then returns your own blood-forming stem cells. Mesenchymal stem cell therapy uses donated Wharton’s Jelly cells that regulate the immune system and involves no chemotherapy.
Research includes both relapsing and progressive MS, with mixed results so far. Our physicians review your MS type, MRI and disability scores to judge whether you are a candidate. No outcome is promised.
Mesenchymal stem cells are recognized for medical use in the European Union and Australia, with hundreds of clinical trials underway worldwide. In December 2024, the FDA approved the first mesenchymal stem cell product in the United States, for steroid-refractory acute graft-versus-host disease in children. For other conditions, mesenchymal stem cell therapy is not FDA-approved in the US.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance. Results vary from patient to patient and no outcome is promised.

Still have a question?
Ask us directly. A patient advocate will reply personally.






